Jamal El-Mosleh
Directeur Général chez ELICERA THERAPEUTICS AB
Postes actifs de Jamal El-Mosleh
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELICERA THERAPEUTICS AB | Directeur Général | 01/01/2020 | - |
| Fondateur | 01/01/2014 | - |
Historique de carrière de Jamal El-Mosleh
Anciens postes connus de Jamal El-Mosleh
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 01/01/2016 | 01/01/2020 |
| ANNEXIN PHARMACEUTICALS AB | Directeur Général | 16/10/2017 | 01/01/2019 |
| Investor Relations Contact | 16/10/2017 | 01/01/2019 | |
| Public Communications Contact | 16/10/2017 | 01/01/2019 | |
| MENDUS AB | Directeur Général | 01/09/2007 | 01/10/2016 |
| Public Communications Contact | 01/09/2007 | 01/10/2016 |
Formation de Jamal El-Mosleh
| Chalmers University of Technology | Graduate Degree |
| Chalmers School of Entrepreneurship | Graduate Degree |
Statistiques
Internationale
| Suède | 7 |
Opérationnelle
| Chief Executive Officer | 3 |
| Public Communications Contact | 2 |
| Graduate Degree | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MENDUS AB | Health Technology |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Technology Services |
- Bourse
- Insiders
- Jamal El-Mosleh
- Expérience
